Although they have been widely used for medical purposes, bisphosphonates have caught dentists' attention in the last few years, only. 9, 11, 13 Nevertheless, we notice great lack of basic scientiic grounds which allow better understanding not only of bisphosphonates mechanism of action, but also their clinical applicability, side Researches on induced tooth movement of animals and humans using bisphosphonates were conducted considering the .
.. May I perform tooth extraction?
Even though the overall answer is yes, understanding the aforementioned questions is essential to develop several researches on 
HISTORY OF BISPHOSPHONATES
Inorganic pyrophosphates are physiological regulators of calcification and bone resorption. Lack of calcium phosphate precipitation in plasma and urine may be attributed to their inhibiting activity. They hinder artery, skin and other organs ectopic calcifications.
However, their therapeutic effects were not satisfactory as the medication remained inactive when orally taken and had rapid hydrolysis when administered via parenteral.
Pyrophosphates were unable to inhibit bone resorption. For this reason, similar medication resistant to enzymatic action was developed: the bisphosphonates. They are characterized by a P-C-P bond instead of P-O-P bond. Additionally, they keep the anti-demineralizing property of pyrophosphates, but remain resistant to hydrolysis. The first synthesis occurred in 8 in Germany and was conducted by Menschutkin.
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Pyrophosphates and bisphosphonates were first used for industrial purposes as anti-corrosive and emollient as well as to prevent calcium carbonate deposition in plumbing systems. Later on, they were proved to be effective not only in controlling calcium phosphate formation and dissolution, but also in bone mineralization and resorption. That was when they began to be used for therapeutic purposes. Up to date, bisphosphonates are used as adhesives, antioxidants, catalysts, corrosion inhibitors, lubricants as well as additive for hydraulic fluids and fuels.
In the early s, Fleish et al enhanced the therapeutic use of bisphosphonates. After three decades of research, bisphosphonates have been rendered indispensable to treat benign or malignant bone diseases. They are effective at inhibiting bone resorption and reducing serum calcium levels in patients with malignant hypercalcemia. Furthermore, they are an important tool used to treat bone metastasis, as they reduce the amount and rate of skeletal complications arising from multiple myeloma and advanced breast cancer. They also relieve pain caused by metastasis arising from different tumors, thereby providing patients with increased quality of life. Bisphosphonates provide benefits to millions of people, controlling osteopenia and osteoporosis.
